Wall Street Analysts See a 33.91% Upside in Collegium Pharmaceutical (COLL): Can the Stock Really Move This High?

Collegium Pharmaceutical (COLL) closed the last trading session at $32.11, gaining 7.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $43 indicates a 33.9% upside potential.The average comprises five short-term price targets ranging from a low of $37.00 to a high of $50.00, with a standard deviation of $5.1. While the lowest estimate indicates an increase of 15.2% from the curren ...